FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313247972> ?p ?o ?g. }

• W4313247972 endingPage "4437" @default.
• W4313247972 startingPage "4429" @default.
• W4313247972 abstract "This study aimed to investigate the incidence rate and risk factors for hepatic encephalopathy (HE) among unresectable hepatocellular carcinoma (uHCC) patients with liver cirrhosis who received sorafenib or lenvatinib treatment.uHCC patients with cirrhosis who received first-line sorafenib or lenvatinib treatment between September 2014 and February 2021 were continually reviewed in our single-center retrospective study. The Hepatic Encephalopathy Scoring Algorithm was used to evaluate the occurrence and grade of HE during treatment, and logistic regression models were used to further explore the risk factors for HE.A total of 454 eligible patients were enrolled in our study, with 214 and 240 patients in the sorafenib and lenvatinib groups, respectively. At time of data cut-off (2021-12), the incidence of HE in sorafenib group (4.2%, 95% CI:2-7%) was significantly lower than that in lenvatinib group (11.3%,95% CI:7-15%) (p = 0.006), with alcoholic cirrhosis [OR: 5.857 (95% CI: 1.519-22.591)], Child-Pugh >7 [OR: 3.023 (95% CI: 1.135-8.053)], blood ammonia ≥38.65 μmol/L [OR: 4.693 (95% CI: 1.782-12.358)], total bile acid ≥29.5 μmol/L [OR: 11.047 (95% CI: 4.414-27.650)] and duration of treatment ≥5.6 months [OR: 4.350 (95% CI: 1.701-11.126)] to be risk factors for the occurrence of HE during first-line systemic therapy.In our study, for off-label uHCC patients (Child-Pugh >7) with alcoholic cirrhosis, hyperammonemia, hypercholesterolemia, and estimated longer duration of treatment, the application of lenvatinib has to be cautious, which needs to be confirmed in future clinical trials." @default.
• W4313247972 created "2023-01-06" @default.
• W4313247972 creator A5003725565 @default.
• W4313247972 creator A5009370871 @default.
• W4313247972 creator A5030413518 @default.
• W4313247972 creator A5036954160 @default.
• W4313247972 creator A5040959671 @default.
• W4313247972 creator A5046610526 @default.
• W4313247972 creator A5062367522 @default.
• W4313247972 creator A5064260340 @default.
• W4313247972 creator A5068989611 @default.
• W4313247972 creator A5074308323 @default.
• W4313247972 creator A5081046147 @default.
• W4313247972 date "2022-12-01" @default.
• W4313247972 modified "2023-10-14" @default.
• W4313247972 title "Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study" @default.
• W4313247972 cites W1543991765 @default.
• W4313247972 cites W1968151513 @default.
• W4313247972 cites W2029773497 @default.
• W4313247972 cites W2031371243 @default.
• W4313247972 cites W2069243984 @default.
• W4313247972 cites W2131743300 @default.
• W4313247972 cites W2142153652 @default.
• W4313247972 cites W2150780222 @default.
• W4313247972 cites W2154239359 @default.
• W4313247972 cites W2162226128 @default.
• W4313247972 cites W2583804433 @default.
• W4313247972 cites W2787358630 @default.
• W4313247972 cites W2789297669 @default.
• W4313247972 cites W2791079921 @default.
• W4313247972 cites W2794063027 @default.
• W4313247972 cites W2801515643 @default.
• W4313247972 cites W2898767814 @default.
• W4313247972 cites W2912812836 @default.
• W4313247972 cites W2923448487 @default.
• W4313247972 cites W2969555800 @default.
• W4313247972 cites W2996066981 @default.
• W4313247972 cites W3021228866 @default.
• W4313247972 cites W3033172330 @default.
• W4313247972 cites W3036509149 @default.
• W4313247972 cites W3045557449 @default.
• W4313247972 cites W3089552331 @default.
• W4313247972 cites W3127516386 @default.
• W4313247972 cites W3128646645 @default.
• W4313247972 cites W3128705663 @default.
• W4313247972 cites W3164797499 @default.
• W4313247972 cites W3165133969 @default.
• W4313247972 cites W3165194593 @default.
• W4313247972 cites W3183089120 @default.
• W4313247972 cites W3213548389 @default.
• W4313247972 cites W4200229374 @default.
• W4313247972 cites W4232620598 @default.
• W4313247972 doi "https://doi.org/10.2147/dddt.s386829" @default.
• W4313247972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36597443" @default.
• W4313247972 hasPublicationYear "2022" @default.
• W4313247972 type Work @default.
• W4313247972 citedByCount "0" @default.
• W4313247972 crossrefType "journal-article" @default.
• W4313247972 hasAuthorship W4313247972A5003725565 @default.
• W4313247972 hasAuthorship W4313247972A5009370871 @default.
• W4313247972 hasAuthorship W4313247972A5030413518 @default.
• W4313247972 hasAuthorship W4313247972A5036954160 @default.
• W4313247972 hasAuthorship W4313247972A5040959671 @default.
• W4313247972 hasAuthorship W4313247972A5046610526 @default.
• W4313247972 hasAuthorship W4313247972A5062367522 @default.
• W4313247972 hasAuthorship W4313247972A5064260340 @default.
• W4313247972 hasAuthorship W4313247972A5068989611 @default.
• W4313247972 hasAuthorship W4313247972A5074308323 @default.
• W4313247972 hasAuthorship W4313247972A5081046147 @default.
• W4313247972 hasBestOaLocation W43132479721 @default.
• W4313247972 hasConcept C120665830 @default.
• W4313247972 hasConcept C121332964 @default.
• W4313247972 hasConcept C126322002 @default.
• W4313247972 hasConcept C2776231280 @default.
• W4313247972 hasConcept C2776264508 @default.
• W4313247972 hasConcept C2777214474 @default.
• W4313247972 hasConcept C2778019345 @default.
• W4313247972 hasConcept C2778695046 @default.
• W4313247972 hasConcept C2780325230 @default.
• W4313247972 hasConcept C61511704 @default.
• W4313247972 hasConcept C71924100 @default.
• W4313247972 hasConcept C90924648 @default.
• W4313247972 hasConceptScore W4313247972C120665830 @default.
• W4313247972 hasConceptScore W4313247972C121332964 @default.
• W4313247972 hasConceptScore W4313247972C126322002 @default.
• W4313247972 hasConceptScore W4313247972C2776231280 @default.
• W4313247972 hasConceptScore W4313247972C2776264508 @default.
• W4313247972 hasConceptScore W4313247972C2777214474 @default.
• W4313247972 hasConceptScore W4313247972C2778019345 @default.
• W4313247972 hasConceptScore W4313247972C2778695046 @default.
• W4313247972 hasConceptScore W4313247972C2780325230 @default.
• W4313247972 hasConceptScore W4313247972C61511704 @default.
• W4313247972 hasConceptScore W4313247972C71924100 @default.
• W4313247972 hasConceptScore W4313247972C90924648 @default.
• W4313247972 hasLocation W43132479721 @default.
• W4313247972 hasLocation W43132479722 @default.
• W4313247972 hasLocation W43132479723 @default.
• W4313247972 hasOpenAccess W4313247972 @default.

• next